Ph II SAHA and Bevacizumab for Recurrent Malignant Glioma Patients
Clinical trial NCT01738646 · COMPLETED
Trial details
- NCT number
- NCT01738646
- Sponsor
- Duke University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-01
- Primary completion
- 2014-12-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.